RSS
Home
Entertainment
Business News
D.C. sniper Muhammad executed for 2002 attacks- John Allen Muhammad, the mastermind behind the sniper attacks that left 10 dead, was executed Tuesday as relatives of the victims watched, reliving the killing spree that terrorized the Washington, D.C., area for three weeks in October 2002.
Blame game erupts over probe of Fort Hood suspect- Finger-pointing erupted between federal agencies Tuesday over Fort Hood shooting suspect Nidal Hasan. Government officials said a Defense Department terrorism investigator looked into Hasan's contacts with a radical imam months ago, but a military official denied prior knowledge of the Army psychiatrist's contacts with any Muslim extremists.
2 dead, 2 wounded in Ore. office park shooting- A woman was killed and two of her co-workers were injured when the woman's estranged husband opened fire Tuesday at a drug-testing laboratory in suburban Portland before turning the gun on himself, police said.
Bill Clinton urges Senate passage of health bill- Former President Bill Clinton urged Senate Democrats on Tuesday to pass health care legislation by year's end, pointedly telling skittish lawmakers that an imperfect bill is preferable to another failure like the one he and the party endured in 1994.
SKorea troops on high alert after navy battle- South Korea's troops went on high alert Wednesday for possible retaliation by North Korea after one of its navy ships was nearly destroyed and an officer reportedly killed in a skirmish with the South, ahead of a visit by President Barack Obama.
White House: Obama weighs 4 options in Afghanistan- President Barack Obama is considering four options for realigning U.S. strategy in Afghanistan, his spokesman said Tuesday, while military officials said the choices involve several ways the president could employ additional U.S. forces next year.
- Male factory workers in China who got very high doses of a chemical that's been widely used in hard plastic bottles had high rates of sexual problems, researchers reported Wednesday.
Swift wins 2nd straight BMI award for top song- Taylor Swift started what could be an interesting week with her second straight song of the year award at the BMI Country Awards Tuesday, when Kris Kristofferson was honored as an icon.
GRAS Status Opens Door to U.S. Food Industry
Phospha E(R) is a patented derivative of vitamin E with superior qualities, such as greater absorption and activity. In pre-clinical studies, Phospha E(R), when given orally, has been shown to lower blood cholesterol and triglyceride levels, inhibit the formation of arterial plaques and suppress the main inflammatory pathways involved in metabolic syndrome (a condition which markedly increases the risk of heart attacks, strokes and diabetes).
The Company is preparing a GRAS notification to inform the U.S. Food and Drug Administration ("FDA") of the expert panel's conclusion that Phosphagenics' Phospha E(R) is GRAS. If the FDA has no further comment, GRAS designation allows manufacturers to produce and sell foods that include Phospha E(R) in the U.S. food industry.
"GRAS status extends the permitted use of Phospha E(R) beyond the nutritional supplement market and into the substantial U.S. food industry, and represents a tremendous commercial opportunity for Phosphagenics," said
APPENDIX AND NOTES TO EDITORS
About GRAS
Generally Recognized as Safe (GRAS) is an FDA designation that a chemical or substance added to food is considered safe by experts, and so is exempted from the usual Federal Food, Drug, and Cosmetic Act (FFDCA) food additive tolerance requirements.
GRAS exemptions are granted for substances that are generally recognized,
among experts qualified by scientific training and experience to evaluate
their safety, as having been adequately shown through scientific procedures
(or, in the case of a substance used in food prior to
The substance must be shown to be "generally recognized" as safe under the conditions of its intended use. The proponent of the exemption has the burden of proving that the use of the substance is "generally recognized" as safe. To establish such recognition, the proponent must show that there is a consensus of expert opinion regarding the safety of the use of the substance.
About Phosphagenics Limited
Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products.
Phosphagenics' core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms.
Phosphagenics' shares are listed on the Australian Stock Exchange (POH)
and the
For more information, please visit Phosphagenics' web site at www.phosphagenics.com
Safe Harbor Statement
This press release contains forward-looking statements based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialise, actual results could vary materially from the Phosphagenics' expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations.
|
|
